NCT03956472

Brief Summary

The purpose of this research is to support a hypothesis that osteopathic manual medicine (OMM) and / or a 10 cmH2O end-expiratory pressure (PEEP) could be used in the prevention of acute mountain sickness (AMS). During altitude exposure, an exaggerated hypoxemia and the increase of intracranial pressure are both known to be major physipathological ways of AMS development. The goal of the osteopathic protocol is to release tension on the circulatory structures directly related to cranial circulation and drainage. The main hypothesis is that it could lead to lower intracranial pressure and help reducing AMS signs. Furthermore the investigators would like to define a osteopathic score for individual AMS sensitivity, based on cranial bones mobility. Several studies have shown that using PEEP at altitude (or hypoxia) increases SpO2. As for osteopathy protocol, the investigators would like to apply this experimental condition during real altitude exposure in a randomized controlled protocol.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

June 17, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

August 30, 2021

Status Verified

August 1, 2021

Enrollment Period

1.3 years

First QC Date

November 16, 2016

Last Update Submit

August 24, 2021

Conditions

Keywords

AltitudeAcute mountain sicknessOsteopathyEnd expiratory pressure

Outcome Measures

Primary Outcomes (1)

  • Changes in Lake Louise Score from baseline to altitude continuous exposure.

    Signs of acute mountain sickness regarding its severity according the official Lake Louise Score.

    mesured and reported every hour during a 10 hours altitude exposure

Secondary Outcomes (1)

  • Changes in numeric scale of well being from baseline to altitude continuous exposure.

    every hour during a 10 hours altitude exposure

Study Arms (3)

Osteopathic group

EXPERIMENTAL

LCS Drainage before altitude exposure

Procedure: Osteopathic protocol for improving drainage of LCSOther: PEEP-Sham

PEEP 10 cmH2O

EXPERIMENTAL

10 min at rest

Device: PEEP 10cmH2OOther: Fake Osteopathic protocol

Control group

SHAM COMPARATOR

Sham PEEP and fake osteopathic protocol

Other: Fake Osteopathic protocolOther: PEEP-Sham

Interventions

Osteopathic intervention improving drainage of LCS and cerebral blood flow through opitmizing veinous circulation

Osteopathic group

Breathing through a 10 cmH2O expiratory resistance for 10 min every 2 hours during 10h at 3842m high

PEEP 10 cmH2O

Placebo intervention

Control groupPEEP 10 cmH2O

PEEP 0 cmH2O (hidden)

Control groupOsteopathic group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy
  • Experienced alpinist
  • No previous acclimatization

You may not qualify if:

  • Heart failure, respiratory failure, kidney failure
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ifremmont

Chamonix, 74400, France

Location

MeSH Terms

Conditions

Altitude Sickness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of research

Study Record Dates

First Submitted

November 16, 2016

First Posted

May 20, 2019

Study Start

June 17, 2017

Primary Completion

October 20, 2018

Study Completion

July 31, 2019

Last Updated

August 30, 2021

Record last verified: 2021-08

Locations